Co-careldopa (levodopa with carbidopa)
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Co-careldopa (levodopa with carbidopa) and local guidelines before prescribing.
Mechanism
Levodopa is a dopamine precursor; carbidopa blocks peripheral decarboxylation.
Uses
Parkinson disease.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, postural hypotension, dyskinesia, motor fluctuations, hallucinations.
Interactions
Dopamine antagonists (metoclopramide, haloperidol) antagonise; MAOIs; iron and protein reduce absorption.
Contraindications and cautions
Narrow-angle glaucoma, melanoma, psychosis
Monitoring
Motor symptoms, BP
Pregnancy and breastfeeding
Avoid unless essential
Renal and hepatic impairment
Caution in cardiac and hepatic disease
Overdose and reversal
Supportive
Special advice
Give on time every time in hospital (missed doses risk akinetic crisis); avoid prochlorperazine and metoclopramide.
More from the textbook: uses, cautions and other points
- Causes - drugs (antihypertensives, diuretics, alpha-blockers, nitrates, antidepressants, levodopa), dehydration, autonomic failure (Parkinson's disease, diabetes, multiple system atrophy), prolonged bed rest.
Cardiology Investigations - Drugs: Tricyclic antidepressants, SNRIs, levodopa, sympathomimetics, phenoxybenzamine, MAOIs.
Endocrinology: Adrenal Disease - Levodopa crosses (via an amino acid carrier), dopamine doesn't ; carbidopa , benserazide and domperidone don't cross - so they act only outside the brain.
Neurology: Anatomy, Physiology and Pharmacology - Hyperkinetic disorders - chorea (Huntington's, levodopa dyskinesia), dystonia, tics, myoclonus, hemiballismus.
Neurology: Anatomy, Physiology and Pharmacology - Always given with a peripheral dopa-decarboxylase inhibitor - carbidopa (co-careldopa - Sinemet) or benserazide (co-beneldopa - Madopar) - to stop conversion outside the brain (less nausea and postural hypotension; more reaches the brain).
Neurology: Anatomy, Physiology and Pharmacology - COMT inhibitors - entacapone , opicapone - taken with levodopa to extend each dose (wearing off); can increase dyskinesias; entacapone turns urine orange; diarrhoea.
Neurology: Anatomy, Physiology and Pharmacology - Advanced treatments - deep brain stimulation, continuous levodopa infusions (intestinal gel, or subcutaneous foslevodopa–foscarbidopa), apomorphine infusion.
Neurology: Anatomy, Physiology and Pharmacology - Neuroleptic malignant syndrome | Antipsychotics, metoclopramide; stopping levodopa or dopamine agonists
Neurology: Anatomy, Physiology and Pharmacology
Where it is discussed in the book
- Cardiology Investigations (1 mention)
- Endocrinology: Adrenal Disease (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (10 mentions)
- Neurology: Emergencies (4 mentions)
- Neurology: Movement Disorders (28 mentions)
- Neurology: Dementia and Cognition Disorders (Complete) (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Psychiatry: assessment, treatment and the law (1 mention)
- Psychiatric emergencies (4 mentions)
- Psychiatry: Mood disorders (1 mention)
- Psychiatry: Psychosis and schizophrenia (2 mentions)
- Medicine of the older adult: Delirium, dementia and mood in older people (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (2 mentions)
- Emergency Medicine: Environmental emergencies (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (4 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (2 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (1 mention)
- Clinical Examination III: Neurological, eye, ENT and musculoskeletal (1 mention)